[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Biopharma_Watch BiopharmaWatch

BiopharmaWatch posts on X about $kura, $adct, san antonio, $4151t the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

X Week XXXXX -XX%
X Month XXXXXX -XX%
X Months XXXXXXX +55%
X Year XXXXXXX +328%

Mentions: XX #

X Week XX -XX%
X Month XXX -XX%
X Months XXXXX +333%
X Year XXXXX +2,329%

Followers: XXXXX #

X Week XXXXX +1.30%
X Month XXXXX +4.90%
X Months XXXXX +61%
X Year XXXXX +142%

CreatorRank: XXXXXXXXX #

Social Influence

Social category influence finance XXX% stocks XXXX% cryptocurrencies XXXX% technology brands XXXX%

Social topic influence $kura #11, $adct #6, san antonio #555, $4151t #1, $2503t #82, $abos #2, virtual 4.35%, $glmd #6, $tara 2.9%, $immp #2

Top accounts mentioned or mentioned by @maximusholla @monacobiotech @boudin420 @martinshkreli @biostocks @yaireinhorn @amaymd @biotech2k1

Top assets mentioned ADC Therapeutics SA (ADCT) Taraxa (TARA) Terns Pharmaceuticals, Inc. Common Stock (TERN) TG Therapeutics, Inc. (TGTX) apM Coin (APM) Biogen Inc (BIIB) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) MetaBeat (BEAT) Adaptive Biotechnologies Corporation Common Stock (ADPT) Curate (XCUR)

Top Social Posts

Top posts by engagements in the last XX hours

"Top Market Movers: Positive News Full Access: $ADCT 4.39$ XXXX% 2025-12-01T21:05:00.000Z ADC Therapeutics Makes Grants to New Employees Under Inducement Plan"
X Link 2025-12-02T15:45Z 1226 followers, XXX engagements

"Latest catalysts: $TLX Catalyst Date - 2025-12-02 Drug - TLX250-CDx (Zircaix189Zr-DFO-girentuximab) Treatment - indeterminate renal masses (IRMs)"
X Link 2025-12-02T15:45Z 1226 followers, XXX engagements

"Latest catalysts: $TARA Catalyst Date - 2025-12-04 Drug - TARA-002 Treatment - Non-muscle invasive bladder cancer (NMIBC)"
X Link 2025-12-03T15:45Z 1226 followers, XXX engagements

"Latest catalysts: $TARA Catalyst Date - 2025-12-04 Drug - TARA-002 Treatment - Non-muscle invasive bladder cancer (NMIBC)"
X Link 2025-12-04T15:45Z 1226 followers, XXX engagements

"$IMMP 1.75$ -XXXX% 2025-12-03T00:00:00.000Z Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium"
X Link 2025-12-05T15:45Z 1228 followers, XXX engagements

"$MDCX 1.72$ -XXXXX% 2025-12-08T00:00:00.000Z Medicus Pharma Ltd. Enters Into $XXX Million Warrant Inducement"
X Link 2025-12-08T15:45Z 1229 followers, XX engagements

"$KURA 11.03$ -XXXX% 2025-12-08T15:30:00.000Z Kura Oncology and Kyowa Kirin Report Combination Data for KOMZIFTI (Ziftomenib) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory AML"
X Link 2025-12-09T15:45Z 1229 followers, XXX engagements

"Top Market Movers: Positive News Full Access: $TERN 18.05$ XXXXX% November X 2025 Terns Announces Abstract with Positive Clinical Data for TERN-701 in Relapsed/Refractory CML Selected for Oral Presentation at 67th ASH Annua"
X Link 2025-11-04T15:45Z 1228 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $QNTM 9.94$ -XXXXX% 2025-11-28T14:30:00.000Z REPEAT: Award-winning Investigative News Program W5 Airs Part X of 3-part Television Series on Alleged Stock Market Manipulation of Q"
X Link 2025-11-28T15:45Z 1228 followers, XXX engagements

"$TGTX 33.15$ -XXXX% 2025-11-28T12:30:00.000Z TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference"
X Link 2025-11-28T15:45Z 1228 followers, XXX engagements

"$ABOS Catalyst Date - 2025-12-02 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease"
X Link 2025-12-02T15:45Z 1228 followers, XX engagements

"$KURA 11.92$ XXXX% 2025-12-03T13:32:00.000Z Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid"
X Link 2025-12-03T15:45Z 1228 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $ADCT 3.23$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup"
X Link 2025-12-03T15:45Z 1228 followers, XXX engagements

"$ABOS Catalyst Date - 2025-12-04 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease"
X Link 2025-12-03T15:45Z 1228 followers, XX engagements

"$KURA 11.92$ XXXX% 2025-12-02T13:02:00.000Z First U.S. Commercial Sale of KOMZIFTI Triggers $XXX Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin"
X Link 2025-12-03T15:45Z 1228 followers, XXX engagements

"$JSPR 1.46$ -XXXX% 2025-12-02T00:00:00.000Z Jasper Therapeutics to Host an Investor Webinar on December 2nd to Present Preliminary Data from ETESIAN Study in Asthma and Findings from BEACON Study Investigation"
X Link 2025-12-03T15:45Z 1228 followers, XX engagements

"$KURA 11.96$ XXXX% 2025-12-03T13:32:00.000Z Kura Oncology to Host Virtual Investor Event to Discuss Data Presented at ASH 2025 on Triplet Combination of Ziftomenib (KOMZIFTI) with Venetoclax and Azacitidine in Newly Diagnosed and Relapsed/Refractory Acute Myeloid"
X Link 2025-12-04T15:45Z 1228 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $ADCT 3.13$ -XXXXX% 2025-12-03T12:30:00.000Z ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA in Combination with Bispecific Antibody Sup"
X Link 2025-12-04T15:45Z 1228 followers, XXX engagements

"$RLMD Catalyst Date - 2025-12-04 Drug - NDV-01 (sustained release intravesical formulation of gemcitabine/docetaxel) Treatment - non-muscle invasive bladder cancer (NMIBC)"
X Link 2025-12-04T15:45Z 1226 followers, XX engagements

"$KURA 11.96$ XXXX% 2025-12-02T13:02:00.000Z First U.S. Commercial Sale of KOMZIFTI Triggers $XXX Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin"
X Link 2025-12-04T15:45Z 1228 followers, XXX engagements

"$ABOS Catalyst Date - 2025-12-04 Drug - Sabirnetug (ACU193) Treatment - Alzheimer's disease"
X Link 2025-12-04T15:45Z 1228 followers, XX engagements

"$IMMP 1.75$ -XXXX% 2025-12-03T00:00:00.000Z Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium"
X Link 2025-12-04T15:45Z 1228 followers, XXX engagements

"Top Market Movers: Positive News Full Access: $INTS 0.39$ XXXX% 2025-12-04T12:47:00.000Z Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium"
X Link 2025-12-05T15:45Z 1227 followers, XXX engagements

"Latest catalysts: $MNOV Catalyst Date - 2025-12-05 Drug - MN-166 (ibudilast) Treatment - Amyotrophic Lateral Sclerosis (ALS)"
X Link 2025-12-05T15:45Z 1227 followers, XXX engagements

"$PRLD Catalyst Date - 2025-12-06 Drug - JAK2V617F mutant selective inhibitors Treatment - myeloproliferative neoplasms (MPNs)"
X Link 2025-12-05T15:45Z 1228 followers, XXX engagements

"Biotech isnt dead. It just needed better tools. BiopharmaWatch cloned what specialist biotech hedge funds hold split it into X risk levels and ran it from Q2 XX Q2 XX. In that period $1M would have grown to as much as $2.33M. Heres how each portfolio behaves 👇 Would love to have your input/feedback on this @Maximus_Holla @monaco_biotech @boudin420 @MartinShkreli @BioStocks @yaireinhorn @A_May_MD @Biotech2k1"
X Link 2025-12-07T23:27Z 1228 followers, XXX engagements

"Under the hood each sleeve holds 1525 names. Q2 XX forward returns by ticker 👇 A few winners drive a big part of the upside Losers hurt but position sizing stops them from killing the portfolio Its a stock-picker alpha inside a rules-based framework"
X Link 2025-12-07T23:29Z 1226 followers, XX engagements

"Not just YOLO oncology. Q2 XX therapeutic mix: Conservative HF: cardio + neuro + immunology + oncology Clinical Growth / High-Vol SMID: oncology & CNS heavy with rare disease spice Midcap Core: more endocrine ophthalmic infectious disease You can see where your risk really is"
X Link 2025-12-07T23:29Z 1226 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $AEMD 3.65$ -XXXXX% 2025-12-08T00:00:00.000Z Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement Priced At-The-Market for Aggregate Gross Proceeds of"
X Link 2025-12-08T15:45Z 1228 followers, XXX engagements

"Latest catalysts: $CGEM Catalyst Date - 2025-12-08 Drug - CLN-049 (FLT3xCD3 bispecific T cell engager) Treatment - relapsed/refractory acute myeloid leukemia (r/r AML) myelodysplastic syndrome (MDS)"
X Link 2025-12-08T15:45Z 1228 followers, XXX engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $IMRN - 972.5K - 21.1M - XXXXX $QCLS - 1.9M - 38.0M - XXXXX $CLNN - 204.9K - 2.8M - 13.85"
X Link 2025-12-08T15:45Z 1228 followers, XXX engagements

"$TERN Catalyst Date - 2025-12-08 Drug - TERN-701 (novel investigational allosteric BCR::ABL1 inhibitor) Treatment - chronic myeloid leukemia (CML)"
X Link 2025-12-08T15:45Z 1228 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $APM 1.69$ -XXXXX% October XX 2025 As part of the planned merger with DiamiR Biosciences Aptorum Group will expand its board and management team with seasoned executives"
X Link 2025-10-10T15:45Z 1229 followers, XXX engagements

"$BIIB Catalyst Date - 2025-12-05 Drug - Zorevunersen (investigational antisense oligonucleotide) Treatment - Dravet syndrome"
X Link 2025-12-05T15:45Z 1229 followers, XX engagements

"$GLMD 1.02$ XXXX% 2025-12-04T13:30:00.000Z Galmed Announces Grant of New Use Patents for the combination of Aramchol and Madrigal Pharmaceuticals' Rezdiffra (Resmetirom) for MASH"
X Link 2025-12-05T15:45Z 1229 followers, XXX engagements

"Top Market Movers: Negative News Full Access: $HURA 1.27$ -XXXXX% 2025-12-08T12:50:00.000Z TuHURA Biosciences Presents Data Demonstrating the Delta Opioid Receptor (DOR) as a New Target in Overcoming Acquired Resistance to I"
X Link 2025-12-09T15:45Z 1229 followers, XXX engagements

"$GLMD 1.17$ -XXXX% 2025-12-08T13:30:00.000Z Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting"
X Link 2025-12-09T15:45Z 1229 followers, XX engagements

"Top Market Movers: Positive News Full Access: $GLMD 1.02$ XXXX% 2025-12-08T13:30:00.000Z Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting"
X Link 2025-12-08T15:45Z 1229 followers, XXX engagements

"$RXRX 4.54$ XXXX% 2025-12-08T12:30:00.000Z Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at XX Weeks"
X Link 2025-12-08T15:45Z 1229 followers, XXX engagements

"Highest Volume Ticker - Price - Volume $LPTX - 2.05$ - 786.0M $PTPI - 0.07$ - 266.5M $BEAT - 1.35$ - 175.3M $OCEA - 0.02$ - 171.4M $CERO - 0.10$ - 114.7M"
X Link 2025-12-10T15:45Z 1229 followers, XXX engagements

"$SANA 4.21$ XXXX% 2025-12-08T14:00:00.000Z Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform"
X Link 2025-12-08T15:45Z 1229 followers, XXX engagements

"$ASBP 0.09$ -XXXXX% 2025-12-03T00:00:00.000Z Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)"
X Link 2025-12-04T15:45Z 1229 followers, 1089 engagements

"$ADPT 17.34$ -XXXX% 2025-12-08T00:00:00.000Z Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ Data Driving Treatment Interventions at 2025 ASH Annual Meeting"
X Link 2025-12-08T15:45Z 1229 followers, XX engagements

"Unusual Volume Ticker - Avg Vol - Cur Vol - Unusual Ratio $SNTI - 2.6M - 73.6M - XXXXX $XCUR - 1.3M - 30.4M - XXXXX $ENSC - 269.4K - 6.0M - 22.12"
X Link 2025-12-10T15:45Z 1229 followers, XXX engagements